home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 364      Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others


Survival and prognostic factors in pediatric patients with medulloblastoma in southern Thailand

Nalita Navaporn, Ratanalert Sanguansin, Kanjanapradit Kanet, Chotsampancharoen Thirachit, Tunthanathip Thara

Year : 2018| Volume: 13| Issue : 2 | Page no: 150-157

   This article has been cited by
1 Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma
Thitiporn Jaruthien, Chonnipa Nantavithya, Sakun Santisukwongchote, Shanop Shuangshoti, Piti Techavichit, Darintr Sosothikul, Jiraporn Amornfa, Kanjana Shotelersuk, Yasunori Sato
PLOS ONE. 2023; 18(1): e0271778
[Pubmed]  [Google Scholar] [DOI]
2 Survival Study in Pediatric Patients with Medulloblastoma in a General Hospital in Tehran, Iran
Sahel Valadan Tahbaz, Hossein Yahyazadeh, Marzieh Beheshti
Forum of Clinical Oncology. 2022; 0(0)
[Pubmed]  [Google Scholar] [DOI]
3 Optimization of Tokuhashi Scoring System to Improve Survival Prediction in Patients with Spinal Metastases
Hung-Kuan Yen, Chih-Wei Chen, Wei-Hsin Lin, Zhong-Yu Wang, Chuan-Ching Huang, Hsuan-Yu Chen, Shu-Hua Yang, Ming-Hsiao Hu
Journal of Clinical Medicine. 2022; 11(18): 5391
[Pubmed]  [Google Scholar] [DOI]
4 A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma
Ariana Pritha, Richard Anderson, David E Anderson, Theodore Nicolaides
Cureus. 2022;
[Pubmed]  [Google Scholar] [DOI]
5 Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups
Asmaa Mustafa Eid, Nehal Abd El-Ghaffar Heabah
Journal of the Egyptian National Cancer Institute. 2021; 33(1)
[Pubmed]  [Google Scholar] [DOI]
6 Epidemiological characteristics and survival outcomes of children with medulloblastoma treated at the National Cancer Institute (INCA) in Rio de Janeiro, Brazil
Gabriela Oigman, Diana S. Osorio, Sima Ferman, Joseph R. Stanek, Antonio Aversa do Souto, Marcio M. C. Christiani, Denise M. A. Magalhaes, Jonathan L. Finlay, Denizar A. Vianna
Pediatric Blood & Cancer. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview
Andrea Cimini, Maria Ricci, Francesca Russo, Martina Egidi, Ferdinando Calabria, Antonio Bagnato, Orazio Schillaci, Agostino Chiaravalloti
Pharmaceuticals. 2021; 14(9): 872
[Pubmed]  [Google Scholar] [DOI]
8 Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study
Xi Chen, Zhen Fan, Kay Ka-Wai Li, Guoqing Wu, Zhong Yang, Xin Gao, Yingchao Liu, Haibo Wu, Hong Chen, Qisheng Tang, Liang Chen, Yuanyuan Wang, Ying Mao, Ho-Keung Ng, Zhifeng Shi, Jinhua Yu, Liangfu Zhou
Neuro-Oncology Advances. 2020; 2(1)
[Pubmed]  [Google Scholar] [DOI]
9 Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time
Somruetai Shuangshoti, Paveen Tadadontip, Piti Techavichit, Paul S. Thorner, Shanop Shuangshoti, Chinachote Teerapakpinyo
Applied Immunohistochemistry & Molecular Morphology. 2020; 28(7): 538
[Pubmed]  [Google Scholar] [DOI]


Read this article